Immune System Key Ltd   Report issue

For profit Phase 2
Founded: Jerusalem Israel (2005)

Organization Overview

First Clinical Trial
2013
NCT01690741
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Immune System Key Ltd